This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Veterinary Biologics Market

Market Insights on Veterinary Biologics covering sales outlook, demand forecast & up-to-date key trends

Veterinary Biologics Market By Product (Vaccines, Bacterial Extracts, Monoclonal Antibody, Immunomodulatory and Allergic Extract), Animal (Companion Animals, Livestock and Equine), Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes and Retail Pharmacies) & Region - Forecast 2022 - 2029

Veterinary Biologics Market Snapshot (2022-2029)

[232 Pages Report] The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is expected to reach US$ 18.2 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.

Veterinary Biologics Market Outlook:

Data Points

Market Insights

Market Value 2021

USD 10.6 Bn

Market Value 2029

USD 18.2 Bn

CAGR 2022-2029

6.9%

Key Players

The key players are Elanco Animal Health, Ceva, Phibro Animal Health Corporation, Boehringer Ingelheim, Zoetis Inc., Merck & Co., Inc., Virbac, Hester Biosciences Limited, Colorado Serum Company, Addison Biological Laboratory, Inc., American Animal Health, Inc., HIPRA, Bimeda Inc. (Texas Vet Lab, Inc.)

Share of Top 5 Countries           

55.7%

Growing demand for processed food items, increasing incidence of foodborne and zoonotic diseases, increasing awareness of pet health in developed and developing countries, improving adoption of inducing “herd immunity” in smaller animals are primary factors boosting growth of the veterinary biologics market.

Moreover, the veterinary healthcare industry is seeing demand for protozoan parasitic vaccines from countries in various regions. All these factors are expected to drive the market growth in forecast period.

Veterinary biologics market holds nearly 36.3% market value share of the US$ 29.2 Bn veterinary medicine market in 2021. In addition, manufacturers in the veterinary biologics market take comprehensive efforts to establish direct customer relations in order to enhance their relationship and trust which leads to the growth of veterinary biologics market.

Global animal production has reduced by 15%–20% annually, mainly due to rising incidence of foodborne and zoonotic diseases. With growing awareness about zoonotic diseases such as brucellosis, bird flu and swine flu, farm owners are increasingly inclined towards proper care of livestock through effective vaccination.

For instances, According to the European Food Safety Authority (EFSA), around 320,000 cases of foodborne and zoonotic diseases are reported each year in the European Union. Campylobacteriosis was the most commonly observed zoonosis in animals, which affected 220,209 people in the EU, due to consumption of infected broiler meat.

Driven by this, sales of veterinary biologics are expected to rise at a 6.9% CAGR through 2029.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1 – 2021

6.99%

H1 – 2022 Projected

6.91%

H1 – 2022 Outlook

6.81%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change– H1, 2022 (O) – H1, 2021

(-) 18 ↓

According to Future Market Insights’ Analysis, the global veterinary biologics market observed a reduced change in the Basis Point Share (BPS) by nearly 18 BPS units in H1- 2022(O) as compared to H1-2021.

This was mostly attributable to breakthroughs in veterinary cell culture, and the introduction of spontaneous animal disease models, which can have more variability and so require more time to examine. H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS.

The key factor boosting the demand for veterinary biologics is the approval of biological medicinal products for marketing in veterinary use by the EMA.

Additionally, as the market is subject to changes influenced by macroeconomic and industrial factors, the growth of the veterinary biologics market is expected to be influenced by devised alternative methods for control of infectious agents, production of thermostable vaccines for veterinary use, and increasing funding for critical research needs for safe development of veterinary biologics.

Moreover, with the observed increase in the rate of affected companion animals after exposure to diseases from humans, and proposed and documented ethical review of clinical studies by a structured review committee, the market is expected to witness a positive shift in terms of value over the forecasted years.

2014-2021 Veterinary Biologics Market Demand Outlook Compared To 2022-2029 Forecast

Sales of Veterinary Biologics grew at a CAGR of 6.5% between 2014 and 2021.

The primary factors boosting the veterinary biologics market growth are increasing awareness of pet health, rising adoption rates and improving adoption of inducing “herd immunity” in smaller animals.

Veterinary Biologics Market Download Report Brochure

Rising awareness of pet health and growing incidence of infectious diseases among pets is projected to fuel revenues of the market. In this regard, it has been estimated that even in developed nations, the proportion of vaccinated companion animals varies between 30% and 50% only. This proportion is as less as 10%-15% in developing countries. However, residents in developed countries are ready to spend money to ensure better health of their pets.

In addition rising demand for pet insurance in developed economies is an ongoing trend. It has been projected that not more than 1% of pet dogs in the U.S. have insurance cover. Considering this, FMI expects the global veterinary biologics market to grow at a CAGR of 6.9% through 2029.

Which Factors Are Restraining Demand For Veterinary Biologics?

Risk from compounding therapy failure and gaps in epidemiological knowledge/ data availability are major restraining factor.

FDA reports that compounded animal drug formulations can pose serious complications to animal health. This may be attributed to factors including errors in compounded drug preparations, inappropriate amount of active ingredient, chemical and physical instability, and deficiency of bioavailability in the target patient.

According to the report, the compounded form of the drug contained 70 times the concentration of the FDA-approved drug, leading to the death of 2 horses and adverse reactions in 11 others. The other study conducted in Florida reported the death of 21 Polo horses from a 10 fold overdose of a selenium compound.

There is a large gap in understanding the epidemiology of veterinary diseases due to differences in disease patterns. A typical example is one for the Newcastle Disease for poultry, and the dearth of epidemiological knowledge for it created serious economic losses in the international poultry trade.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-Wise Insights

What Makes the U.S. a Large Market for Veterinary Biologics?

The U.S. is estimated to account for around 87.1% of the North America veterinary biologics market in 2022.  

Rebound of economic prosperity in the developed markets has led to an increased demand for processed and healthy meat products. This fuels demand for effective vaccination of livestock, in nations such as U.S. Increasing consumer health awareness leads to rising consumer preference for lean white meat and fish over red meat. This is expected to drive growth of the poultry and aquaculture segment.

The animal health industry has a high impact economically and a large social contribution. Keeping animals healthy also helps in keeping humans healthy, which is further expected to drive demand for veterinary biologics over the forecast period.

This involves 850 prominent scientists, physicians, and veterinarians worldwide. Devising complementary and harmonized approaches to understand disease transmission mechanisms along with protection and persistence could help in more rational design of veterinary vaccines. This could help in better tackling emerging and remerging infections – 70% of which are vector-borne or chronic in nature. All these can drive the demand in U.S market

Why is Germany Considered a Lucrative Veterinary Biologics Market?

Germany is estimated to grow with CAGR 7.2% in the veterinary biologics market in Europe in 2022.

Growing awareness amongst the population regarding animal diseases, rise in the adoption of animal health facilities in Europe and healthcare scheme for companion insurance, which is applied to surge the efficiency of animal healthcare systems in Germany is expected to drive the market growth.

What are the Factors Fueling the Demand for Veterinary Biologics in U.K?

The veterinary biologics market in U.K is estimated to be worth US$ 644.0 Mn in 2022 in the global market.

U.K’s greater attention is on invention on product used in treatment of zoonotic diseases coupled with developments in biotechnology, which is expected to create a favorable platform for development of veterinary vaccines in high-income economies.

These techniques include next-generation sequencing, synthetic biology, and systems biology. Continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency, and shorten time-to-market for new veterinary vaccines.

Also, favorable pet insurance help in rise the adoption of pets in U.K that helps the growth of the market in this region.

How will the Veterinary Biologics Market Expand across India?

Demand for veterinary biologics in India is expected to rise at around 7.7% CAGR over the forecast period.

The increasing prevalence as well as incidence of zoonotic disease are major public health concerns. Zoonotic diseases are transmitted by animals to humans. More than 70% of human infectious diseases are caused by pathogens shared by wild and domestic animals.

The major pathogens and diseases associated with zoonotic are Ebola hemorrhagic fever, anthrax, rift valley fever, brucellosis, Chagas disease, an influenza, severe acute respiratory syndrome (SARS), leptospirosis, cysticercoids and echinococcosis, and toxoplasmas.

Many foodborne zoonotic diseases such as bovine tuberculosis, brucellosis, salmonellosis, and some helminth infections especially occur in low-income and middle-income countries like India creating high risk related to foodborne disease.

Category-Wise Insights

Demand for Vaccines continue gaining Traction

By Product, Vaccines are anticipated to hold the maximum share of 91.4% in 2022, expanding at rate of nearly 6.5% during the forecast period.

Unification of veterinary drugs/biologics research along with research in human medicine is being undertaken through leading nodal healthcare agencies such as the American Medical Association, American Veterinary Medical Association, the American Society of Tropical Medicine and Hygiene, the CDC, the USDA, and the U.S. National Environmental Health Association (NEHA) for development of vaccines. This is anticipated to surge their adoption of vaccines and drive the demand.

Why Livestock will hold the most of the market share?

By Animal Type, Livestock is leading the market and is projected to account for 51.7% of the total market revenue share in 2022.

Increasing demand for the processed animal origin food, high adoption of dairy product and also USDA’s classification of pork, veal, beef, and lamb (mutton) as livestock, and all livestock are all the prime factors generating significant incremental opportunity for livestock animal segment growth in veterinary biologics market.

Why Veterinary Clinics Projected Maximum Growth in the Veterinary Biologics Market?

By distribution channel, veterinary clinics is anticipated to hold the maximum share of 41.3% in 2022, expanding at rapid rate of 7.3% CAGR during the forecast period.

The growing adoption of pet and increasing number of walk-in patient in hospitals is leading to the growing market share of veterinary clinics. Veterinary clinics is the place where all primary care is taken in clinics so most of pet care is done there. Hence an increased share is seen from clinics.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

Companies operating in the veterinary biologics market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:

  • In July 2020 – Zoetis acquired Benchmark Holdings, PLC, as a strategic addition to its pharma business, which develops and commercializes fish vaccines and offers services in vaccination and diagnostics for aquaculture.
  • In March 2021, Elanco Animal Health company launched its newest innovation for Cats, Elura™ (capromorelin oral solution), for chronic kidney diseases to U.S. veterinarians.

Scope Of The Report

Attribute

Details

Forecast Period

2014-2021

Historical Data Available for

2022-2029

Market Analysis

USD Billion for Value

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Australia, New Zealand, GCC Countries, South Africa, Turkey

Key Segments Covered

Product, Animal, Distribution Channel and Region

Key Companies Profiled

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Veterinary Biologics Market By Category

By Product

  • Vaccines
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Bacterial Extracts
  • Monoclonal Antibody
  • Immunomodulatory
    • Cytokines
    • Others
  • Allergenic Extracts

By Animal

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock
    • Aquatic
    • Bovine
    • Porcine
    • Ovine/Caprine
    • Poultry
  • Equine

By Distribution Channel

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is set to expand 1.6X over the forecasted years owing to the rising number of pet adoption and increasing incidence of foodborne and zoonotic diseases.

The sales of veterinary biologics in the market have grown at a CAGR of nearly 6.5% between 2014 and 2021.

The veterinary biologics market is expected to reach US$ 18.2 Bn by the end of 2029 with sales revenue expected to register CAGR of 6.9% over the forecast period.

North America currently holds the largest market share in the veterinary biologics. U.S. being the leading contributor with a market value over US$ 3.1 Bn in 2022.

Demand of veterinary biologics market is expected to register growth in Europe at rate of 6.7% CAGR during the forecast period.

The veterinary biologics in China is likely to observe growth with an impressive CAGR of 8.1% during the forecast period. The market in China is driven by the increasing awareness of pet health in china and growing technological advancements in biologics.

Acquisitions by big players, enhancing direct customer interactions, growing focus on developing protozoan parasitic vaccines, smaller players- limited room for growth and adoption of pet insurance in matured markets are key trends driving sales of veterinary biologics market across the globe.

Japan’s veterinary biologics market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.8% CAGR during the forecast period. South Korea market expected to exhibit healthy growth of 6.3% CAGR during the forecast period.

U.S., China, Italy, U.K, and Germany are the top 5 countries that are driving the demand for Veterinary Biologics market.

Leading companies of veterinary biologics are Elanco Animal Health, Ceva, Phibro Animal Health Corporation, Boehringer Ingelheim, Zoetis Inc., Merck & Co., Inc., Virbac, Hester Biosciences Limited, Colorado Serum Company, Addison Biological Laboratory, Inc., American Animal Health, Inc., HIPRA, Bimeda Inc. (Texas Vet Lab, Inc.)

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Key Success Factors

    4.1. Regulatory Scenario

5. Global Veterinary Biologics Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021and Forecast, 2022-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

    6.2. Forecast Factors - Relevance & Impact

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Product 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Product, 2014 - 2021

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022 - 2029

        7.3.1. Vaccines

            7.3.1.1. Attenuated Live Vaccines

            7.3.1.2. Conjugate Vaccines

            7.3.1.3. Inactivated Vaccines

            7.3.1.4. Subunit Vaccines

            7.3.1.5. Toxoid Vaccines

            7.3.1.6. DNA Vaccines

            7.3.1.7. Recombinant Vaccines

        7.3.2. Bacterial Extracts

        7.3.3. Monoclonal Antibody

        7.3.4. Immunomodulators

            7.3.4.1. Cytokines

            7.3.4.2. Others

        7.3.5. Allergenic Extracts

    7.4. Market Attractiveness Analysis By Product 

8. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Animal 

    8.1. Introduction / Key Findings

    8.2. Historical Veterinary Biologics Market Size (US$ Mn) Analysis By Animal, 2014 - 2021

    8.3. Current and Future Veterinary Biologics Market Size (US$ Mn) Analysis By Animal, 2022 - 2029

        8.3.1. Companion Animals

            8.3.1.1. Canine

            8.3.1.2. Avian

            8.3.1.3. Feline

        8.3.2. Livestock Animals

            8.3.2.1. Aquatic

            8.3.2.2. Bovine

            8.3.2.3. Porcine

            8.3.2.4. Ovine/Caprine

            8.3.2.5. Poultry

        8.3.3. Equine

    8.4. Market Attractiveness Analysis of Antitoxins Market By Animal

9. Global Veterinary Biologics - Cytokines Market Analysis 2014-2021 and Forecast 2022-2029, by Animal 

    9.1. Historical Cytokines Market Size (US$ Mn) Analysis By Animal, 2014 - 2021

    9.2. Current and Future Cytokines Market Size (US$ Mn) Analysis By Animal, 2022 - 2029

        9.2.1. Companion Animals

            9.2.1.1. Canine

            9.2.1.2. Avian

            9.2.1.3. Feline

        9.2.2. Livestock Animals

            9.2.2.1. Aquatic

            9.2.2.2. Bovine

            9.2.2.3. Porcine

            9.2.2.4. Ovine/Caprine

            9.2.2.5. Poultry

        9.2.3. Equine 

10. Global Veterinary Biologics - Other Immunomodulatory Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Animal 

    10.1. Historical Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal, 2014 - 2021

    10.2. Current and Future Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal, 2022 - 2029

        10.2.1. Companion Animals

            10.2.1.1. Canine

            10.2.1.2. Avian

            10.2.1.3. Feline

        10.2.2. Livestock Animals

            10.2.2.1. Aquatic

            10.2.2.2. Bovine

            10.2.2.3. Porcine

            10.2.2.4. Ovine/Caprine

            10.2.2.5. Poultry

        10.2.3. Equine 

11. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel 

    11.1.  Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2029

        11.3.1. Veterinary Clinics

        11.3.2. Veterinary Hospitals

        11.3.3. Veterinary Research Institutes

        11.3.4. Retail Pharmacies

    11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Animal, 2014 - 2021

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. South Asia

        12.3.5. East Asia

        12.3.6. Oceania

        12.3.7. Middle East & Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By Animal

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Animal

        13.4.4. By Distribution Channel

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Rest of Latin America

        14.3.2. By Product

        14.3.3. By Animal

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Animal

        14.4.4. By Distribution Channel

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    15.3. Market Size (US$ Mn) and By Market Taxonomy, 2022 - 2029

        15.3.1.  By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By Animal

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Animal

        15.4.4. By Distribution Channel

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        16.3.1.  By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product

        16.3.3. By Animal

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Animal

        16.4.4. By Distribution Channel

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        17.3.1.  By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product

        17.3.3. By Animal

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Animal

        17.4.4. By Distribution Channel

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By Animal

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Animal

        18.4.4. By Distribution Channel

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. MEA Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    19.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        19.4.1.  By Country

            19.4.1.1. GCC Countries

            19.4.1.2. Turkey

            19.4.1.3. Northern Africa

            19.4.1.4. South Africa

            19.4.1.5. Rest of MEA

        19.4.2. By Product

        19.4.3. By Animal

        19.4.4. By Distribution Channel

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By Animal

        19.5.4. By Distribution Channel

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

20. Emerging Countries Veterinary Biologics Market Analysis 2022 & 2029

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. China Veterinary Biologics Market Analysis

        20.2.1. Introduction

        20.2.2. PEST Analysis

        20.2.3. Market Value Proportion Analysis by Market Taxonomy

        20.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.2.4.1. By Product

            20.2.4.2. By Animal

            20.2.4.3. By Distribution Channel

    20.3. India Veterinary Biologics Market Analysis

        20.3.1. Introduction

        20.3.2. PEST Analysis

        20.3.3. Market Value Proportion Analysis by Market Taxonomy

        20.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.3.4.1. By Product

            20.3.4.2. By Animal

            20.3.4.3. By Distribution Channel

    20.4. Brazil Veterinary Biologics Market Analysis

        20.4.1. Introduction

        20.4.2. PEST Analysis

        20.4.3. Market Value Proportion Analysis by Market Taxonomy

        20.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.4.4.1. By Product

            20.4.4.2. By Animal

            20.4.4.3. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. Product foot print by Players

        21.4.2. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. Elanco Animal Health

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. Ceva

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Phibro Animal Health Corporation 

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Boehringer Ingelheim

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. Zoetis, Inc.

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. Merck Animal Health

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. Virbac

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. Hester Biosciences Limited

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Colorado Serum Company

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Addison Biological Laboratory, Inc.

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy

        22.3.11. American Animal Health, Inc.

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Product Strategy

                22.3.11.5.3. Channel Strategy

        22.3.12. HIPRA

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.12.4. Sales Footprint

            22.3.12.5. Strategy Overview

                22.3.12.5.1. Marketing Strategy

                22.3.12.5.2. Product Strategy

                22.3.12.5.3. Channel Strategy

        22.3.13. Bimeda Inc. (Texas Vet Lab, Inc.)

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.13.4. Sales Footprint

            22.3.13.5. Strategy Overview

                22.3.13.5.1. Marketing Strategy

                22.3.13.5.2. Product Strategy

                22.3.13.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 02: Global Veterinary Cytokines Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 03: Global Veterinary Other Immunomodulatory Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 04: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 05: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 06: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region

Table 07: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 08: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 09: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 10: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 11: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 12: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 13: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 14: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 15: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 16: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 17: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 18: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 19: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 20: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 21: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 22: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 23: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 24: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 25: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 26: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 27: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 28: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 29: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 30: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 31: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 32: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 33: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 34: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 35: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 36: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 37: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 38: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 39: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 40: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 41: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product

Table 42: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal

Table 43: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global veterinary biologics Historical Market Size and Y-o-Y, 2014-2021

Figure 02: Global veterinary biologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029

Figure 03: Global veterinary biologics Market Absolute $ Opportunity, 2014–2029

Figure 04: Global Veterinary Biologics Market Share Analysis (%) By Product, 2022 & 2029

Figure 05: Global Veterinary Biologics Market Y-o-Y Growth (%) By Product, 2022–2029

Figure 06: Global Veterinary Biologics Market Attractiveness Analysis, By Product

Figure 07: Global Veterinary Biologics Market Share Analysis (%) By Animal, 2022 & 2029

Figure 08: Global Veterinary Biologics Market Y-o-Y Growth (%) By Animal, 2022–2029

Figure 09: Global Veterinary Biologics Market Attractiveness Analysis, By Animal

Figure 10: Global Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 11: Global Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 12: Global Veterinary Biologics Market Attractiveness Analysis, By Distribution Channel

Figure 13: Global Veterinary Biologics Market Share Analysis (%) By Region, 2022 & 2029

Figure 14: Global Veterinary Biologics Market Y-o-Y Growth (%) By Region, 2022–2029

Figure 15: Global Veterinary Biologics Market Attractiveness Analysis, By Region

Figure 16: North America Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 17: North America Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 18: North America Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 19: North America Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 20: North America Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 21: North America Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 22: North America Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 23: North America Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 24: North America Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 25: North America Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 26: North America Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 27: North America Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 28: North America Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 29: North America Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 30: Latin America Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 31: Latin America Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 32: Latin America Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 33: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 34: Latin America Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 35: Latin America Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 36: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 37: Latin America Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 38: Latin America Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 39: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 40: Latin America Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 41: Latin America Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 42: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 43: Latin America Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 44: Europe Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 45: Europe Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 46: Europe Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 47: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 48: Europe Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 49: Europe Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 50: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 51: Europe Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 52: Europe Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 53: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 54: Europe Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 55: Europe Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 56: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 57: Europe Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 58: South Asia Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 59: South Asia Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 60: South Asia Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 61: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 62: South Asia Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 63: South Asia Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 64: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 65: South Asia Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 66: South Asia Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 67: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 68: South Asia Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 69: South Asia Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 70: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 71: South Asia Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 72: East Asia Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 73: East Asia Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 74: East Asia Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 75: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 76: East Asia Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 77: East Asia Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 78: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 79: East Asia Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 80: East Asia Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 81: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 82: East Asia Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 83: East Asia Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 84: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 85: East Asia Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 86: Oceania Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 87: Oceania Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 88: Oceania Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 89: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 90: Oceania Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 91: Oceania Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 92: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 93: Oceania Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 94: Oceania Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 95: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 96: Oceania Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 97: Oceania Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 98: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 99: Oceania Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 100: MEA Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 101: MEA Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 102: MEA Veterinary Biologics Market Analysis by Country – 2022 & 2029

Figure 103: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029

Figure 104: MEA Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029

Figure 105: MEA Veterinary Biologics Market Analysis by Product – 2022 & 2029

Figure 106: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029

Figure 107: MEA Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 108: MEA Veterinary Biologics Market Analysis by Animal  –2022 & 2029

Figure 109: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029

Figure 110: MEA Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 111: MEA Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029

Figure 112: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 113: MEA Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 114: Emerging countries Veterinary Biologics Market Size (US$ Mn) Analysis, 2022

Figure 115: Emerging countries Veterinary Biologics Market Size (US$ Mn) 2014 – 2029

Figure 116: China Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 117: China Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 118: China Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 119: China Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 120: China Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 121: India Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 122: India Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 123: India Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 124: India Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 125: India Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Figure 126: Brazil Veterinary Biologics Market Size (US$ Mn), 2014-2021

Figure 127: Brazil Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 128: Brazil Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029

Figure 129: Brazil Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029

Figure 130: Brazil Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Veterinary Lasers Market

Published : December 2021

Healthcare

Veterinary Ultrasound Scanners Market

Published : January 2022

Healthcare

Veterinary Biologics Market

Published : March 2022

Healthcare

Veterinary Vaccines Market

Published : February 2022

Google translate

Veterinary Biologics Market